Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone.

Supplementation With Hyaluronic Acid, Alpha-lipoic Acid, Magnesium, and Vitamin D and B6 in Patients at Risk of Abortion Treated With Progesterone: a Pilot Study.

The trial aims to investigate the effect of supplementation with hyaluronic acid, alpha-lipoic acid, magnesium, vitamin D and vitamin B6 in progesterone-treated pregnant women with risk factors for abortion.

Inclusion Criteria:

• Women with risk factor for abortion (sub-chorionic hematoma during gestation or ART procedures)

Exclusion Criteria:

• Other pregnancy-related conditions
• Diabetes or hypertension
• Concomitant pharmacological therapies (anticoagulant or antihypertensive)
• Use of tocolytic drugs two months prior to enrollment
• Association with hypoglycemic drugs